Screener
Apogee Therapeutics, Inc. APGE Income Tax
Income Tax at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215698
| Line item | THREE MONTHS ENDEDMARCH 31, 2026 | THREE MONTHS ENDEDMARCH 31, 2025 |
|---|---|---|
| Other income, net: | ||
| Interest income, net | 8,740 | 7,840 |
| Total other income, net | 8,740 | 7,840 |
| Net loss before taxes | (74,032) | (55,256) |
| Provision for income taxes | (79) | (83) |
| Net loss after taxes | $(74,111) | $(55,339) |
| Net loss per share, basic and diluted | $(1.06) | $(0.95) |
| Weighted-average common shares outstanding, basic and diluted | 69,668,439 | 58,195,272 |
Item 6. [Exhibits](#item_6_exhibits) [71](#item_6_exhibits)
FAQ
- What is Apogee Therapeutics, Inc.'s income tax?
- Apogee Therapeutics, Inc. (APGE) reported income tax of $79K in Q1 2026.
- How has Apogee Therapeutics, Inc.'s income tax changed year-over-year?
- Apogee Therapeutics, Inc.'s income tax decreased by 4.8% year-over-year, from $83K to $79K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about Apogee Therapeutics, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude